TrialBritish journal of clinical pharmacology2002

Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers.

Paul D Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.